Medication Understanding in MS
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Multiple Sclerosis. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Home-based Assessment of Medication Understanding and Use in People With Multiple Sclerosis
Overview
The goal of this observational study is to learn how people with multiple sclerosis (MS) understand, organise, and use their medicines at home. The study aims to explore how people take their prescribed and non-prescribed medicines, what challenges they experience, and whether any safety issues arise in day-to-day medication use. Participants will take part in one home visit with trained student researchers. During the visit, researchers will review all medicines and supplements the participant uses, ask about routines and any difficulties, check medication packaging with permission, and ask a brief question about memory. No treatment changes will be made. Information will be reviewed by a senior clinician, and any safety concerns will be shared with the participant's usual healthcare team.
Primary outcome measures
- Medication Burden (Descriptive) [Time frame: Baseline]
Secondary outcome measures (5)
- Medication Adherence (MARS-5 Score) [Time frame: Baseline]
- Medication-Related Challenges [Time frame: Baseline]
- Subjective Cognitive Decline (Single-Item Question) [Time frame: Baseline]
- Medication Organisation and Use of Aids [Time frame: Baseline]
- Medication Storage and Safety Issues [Time frame: Baseline]
Eligibility criteria
Inclusion criteria
- Adults aged 18 years and over with a confirmed diagnosis of multiple sclerosis
- Living in the community (not in residential care)
- Taking at least one prescribed medication
- Able to provide informed consent or, for those without capacity to provide informed consent, with a consultee available to provide consultee declaration and provide information during home-based medication review
- Willing and able to participate in a home-based medication review
Exclusion criteria
- Severe cognitive or communication impairment without a consultee to provide consultee declaration and medication-related information
- Participants for whom a home visit is deemed unsafe
- Non-English speakers
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Other
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07518381 · 26008 · 368655